You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ms

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Cognitive Dysfunction, Memory Disorders Trial (HOme-Based Self-management and COgnitive Training CHanges

Not yet recruiting
  • Multiple Sclerosis
  • +2 more
  • HOme-Based Self-management and COgnitive Training CHanges lives (HOBSCOTCH)
  • (no location specified)
Nov 17, 2023

Multiple Sclerosis Trial in Aarhus C (MS Ballroom Fitness)

Recruiting
  • Multiple Sclerosis
  • MS Ballroom Fitness
  • Aarhus C, Jutland, Denmark
    Aarhus University, Exercise Biology
Sep 12, 2023

Primary Aldosteronism LC-MS/MS-specific Cutoffs

Recruiting
  • Primary Aldosteronism
  • Captopril Challenge Test
  • Chongqing, Chongqing, China
  • +1 more
Jul 24, 2023

Integrated Digital Solutions in Medical Care of Multiple

Not yet recruiting
  • Relapsing Remitting Multiple Sclerosis
  • MS Care Platform (icobrain ms and icompanion ms)
  • (no location specified)
Jul 10, 2023

Hyperaldosteronism; Primary Trial in Caen (Aldosterone in HPLC-MS/MS)

Recruiting
  • Hyperaldosteronism; Primary
  • Aldosterone in HPLC-MS/MS
  • Caen, France
    CAEN University Hospital
Nov 28, 2022

Detecting Changes in Multiple Sclerosis (MS) Condition

Not yet recruiting
  • Multiple Sclerosis
    • (no location specified)
    Mar 10, 2023

    Multiple Sclerosis Trial in Cleveland (Group Dance and Movement Training)

    Recruiting
    • Multiple Sclerosis
    • Group Dance and Movement Training
    • Cleveland, Ohio
      Cleveland State University
    Jul 9, 2023

    Multiple Sclerosis Trial in North Haven (biological samples)

    Recruiting
    • Multiple Sclerosis
    • biological samples
    • North Haven, Connecticut
      Yale University
    Mar 30, 2023

    Multiple Sclerosis, MS, Depression Trial in San Francisco (MS CATCH)

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • MS CATCH
    • San Francisco, California
      Weill Institute for Neurosciences, University of California, San
    May 9, 2023

    Pancreatic Cancer, Cachexia, Chemo Effect Trial in Taipei (MS-20, Placebo)

    Recruiting
    • Pancreatic Cancer
    • +2 more
    • Taipei, Taiwan
      Department of Internal Medicine, National Taiwan University Hosp
    Jan 17, 2023

    Integrated Proteomic HPLC-ESI-MS Analysis of Salivary Peptides

    Active, not recruiting
    • Bronchopulmonary Dysplasia; Retinopathy of Prematurity
    • Integrated proteomic HPLC-ESI-MS analysis of salivary peptides
    • Roma, Italy
      Fondazione Policlinico Universitario A. Gemelli IRCCS
    Mar 13, 2023

    Quality of Life of Multiple Sclerosis Patients Treated With

    Not yet recruiting
    • Multiple Sclerosis (MS)
    • ofatumumab
    • (no location specified)
    Nov 27, 2023

    Multiple Sclerosis Trial (Cognitive training, Motor training)

    Recruiting
    • Multiple Sclerosis
    • Cognitive training
    • Motor training
    • Brussel, Belgium
    • +1 more
    Nov 4, 2022

    Multiple Sclerosis, Obesity Trial in Kansas City (behavioral telehealth, Treatment as Usual)

    Active, not recruiting
    • Multiple Sclerosis
    • Obesity
    • behavioral telehealth
    • Treatment as Usual
    • Kansas City, Missouri
      University of Missouri-Kansas City
    Nov 1, 2022

    Advanced Solid Tumor Trial in Bengbu, Hefei, Changsha (TT-00973-MS tablets treatment)

    Not yet recruiting
    • Advanced Solid Tumor
    • TT-00973-MS tablets treatment
    • Bengbu, Anhui, China
    • +2 more
    Jan 9, 2023

    Corrona Multiple Sclerosis (MS) Registry

    Enrolling by invitation
    • Multiple Sclerosis
      • Waltham, Massachusetts
        Corrona, LLC
      Nov 9, 2022

      End of Dose Phenomena in Subcutaneous Natalizumab Treated

      Not yet recruiting
      • Multiple Sclerosis
      • (no location specified)
      Jan 18, 2023

      Prediabetes and Diabetes Based on MALDI-TOF MS Platform.

      Recruiting
      • Prediabetes
      • +3 more
      • Oral Glucose Tolerance Test
      • Guangzhou, Guangdong, China
        Zhujiang Hospital of Southern Medical University
      Oct 18, 2023

      Determining Cognitive, Energetic, Behavioural and Affective

      Recruiting
      • Multiple Sclerosis
      • There is no intervention.
      • Groningen, Netherlands
        University Medical Center Groningen (UMCG)
      Aug 25, 2023

      COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients

      Completed
      • Multiple Sclerosis
      • Covid19
        • New York, New York
          NYU Langone Health
        Nov 2, 2022

        Ocrelizumab Effects on the Metabolome in MS

        Active, not recruiting
        • Multiple Sclerosis
        • Baltimore, Maryland
          Johns Hopkins University
        Jan 30, 2023

        Trabecular Bone Score in Multiple Sclerosis

        Completed
        • Multiple Sclerosis
        • +2 more
        • sm tbs group
        • Messina, Italy
          IRCCS Centro Neurolesi Bonino Pulejo
        Mar 31, 2023

        COVID-19 Vaccine Response in Treated MS Patients

        Recruiting
        • Multiple Sclerosis
        • Healthy
        • Blood draw
        • Boston, Massachusetts
          Brigham MS Center
        Jul 26, 2022

        Long-Term Safety of Vumerity and Tecfidera in Multiple Sclerosis

        Not yet recruiting
        • Multiple Sclerosis
        • Diroximel Fumarate
        • +2 more
        • (no location specified)
        Mar 2, 2023

        Multiple Sclerosis (MS) Trial in Birmingham (Physical activity behavioral intervention in persons newly diagnosed with MS)

        Recruiting
        • Multiple Sclerosis (MS)
        • Physical activity behavioral intervention in persons newly diagnosed with MS
        • Birmingham, Alabama
          University of Alabama at Birmingham
        Jan 24, 2023